Search Results - "Grimm, MO"

Refine Results
  1. 1

    Clinical Outcome of Patients with Lymph Node Positive Prostate Cancer after Radical Prostatectomy versus Androgen Deprivation by Grimm, M.-O, Kamphausen, S, Hugenschmidt, H, Stephan-Odenthal, M, Ackermann, R, Vögeli, T.A

    Published in European urology (01-06-2002)
    “…Objective(s): To compare the outcome of patients with stage D1 (TxN+M0) prostate cancer undergoing radical prostatectomy or androgen deprivation alone…”
    Get full text
    Journal Article
  2. 2

    Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study by Jocham, Dieter, Witjes, Fred, Wagner, Sigrid, Zeylemaker, Bram, van Moorselaar, Jeroen, Grimm, Marc-Oliver, Muschter, Rolf, Popken, Gralf, König, Frank, Knüchel, Ruth, Kurth, Karl-Heinz

    Published in The Journal of urology (01-09-2005)
    “…We determined if improved tumor detection using hexaminolevulinate (HAL) fluorescence cystoscopy could lead to improved treatment in patients with bladder…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study by Grimm, Marc-Oliver, Steinhoff, Christine, Simon, Xenia, Spiegelhalder, Philipp, Ackermann, Rolf, Vogeli, Thomas Alexander

    Published in The Journal of urology (01-08-2003)
    “…We determined the long-term outcome in patients with superficial bladder cancer (Ta and T1) undergoing routine second transurethral bladder tumor resection…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles by MODLICH, Olga, PRISACK, Hans-Bernd, PITSCHKE, Gerald, RAMP, Uwe, ACKERMANN, Rolf, BOJAR, Hans, VÖGELI, Thomas A, GRIMM, Marc-Oliver

    Published in Clinical cancer research (15-05-2004)
    “…Expression profiling by DNA microarray technology permits the identification of genes underlying clinical heterogeneity of bladder cancer and which might…”
    Get full text
    Journal Article
  7. 7
  8. 8

    KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells by MARREIROS, Alexandra, DUDGEON, Kip, DAO, Vinh, GRIMM, Marc-Oliver, CZOLIJ, Robert, CROSSLEY, Merlin, JACKSON, Paul

    Published in Oncogene (20-01-2005)
    “…A molecular mechanism to explain reduced KAI1 expression in invasive and metastatic tumour cells remains elusive. In this report, we extend an earlier study in…”
    Get full text
    Journal Article
  9. 9

    Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines by Nixdorf, Sheri, Grimm, Marc-Oliver, Loberg, Robert, Marreiros, Alexandra, Russell, Pamela J., Pienta, Kenneth J., Jackson, Paul

    Published in Cancer letters (25-11-2004)
    “…It has been proposed that a 356 amino acid protein encoded by the MIM (Missing In Metastasis) gene on Chromosome 8q24.1, is a bladder cancer metastasis…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status by Maas, Simone, Warskulat, Ulrich, Steinhoff, Christine, Mueller, Wolfram, Grimm, Marc-Oliver, Schulz, Wolfgang A, Seifert, Hans-Helge

    Published in Urology (Ridgewood, N.J.) (01-02-2004)
    “…The Fas-Fas ligand system is an important regulator of apoptosis and is involved in tumor development. Invasive cancers downregulate Fas expression to evade…”
    Get full text
    Journal Article
  12. 12

    Anemia under androgen deprivation: influence of flutamide, cyproteroneacetate and orchiectomy on the erythropoietin system by Voegeli, T-A, Kurtz, A, Grimm, M O, Effert, P, Eckardt, K-U

    Published in Hormone and metabolic research (01-02-2005)
    “…There is a high incidence of anemia in patients with advanced prostate cancer (PC) under androgen deprivation. Pathophysiology of this anemia remains unclear…”
    Get more information
    Journal Article
  13. 13

    Frequent and heterogenous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma by CLASEN, S, SCHULZ, W. A, GERHARZ, C.-D, GRIMM, M.-O, CHRISTOPH, F, SCHMITZ-DRÄGER, B. J

    Published in British journal of cancer (01-02-1998)
    “…The inhibitor of cyclin-dependent kinases WAF1/p21 has been shown to mediate cell cycle arrest by p53 and other factors. We have studied its expression in…”
    Get full text
    Journal Article
  14. 14

    Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines by Jackson, Paul, Grimm, Marc-Oliver, Kingsley, Elizabeth A, Brosius, Ute, Antalis, Toni, Yardley, Gina, Russell, Pamela J

    Published in Urologic oncology (01-05-2002)
    “…The molecular basis for the loss of KAI1 expression in invasive and metastatic tumors and tumor cell lines is not understood. Recently, identification of a…”
    Get full text
    Journal Article
  15. 15

    Primary treatment of ureteral stones by new multiline lithotripter by Bendhack, M L, Grimm, M O, Ackermann, R, Vögeli, T

    Published in Journal of endourology (01-06-1999)
    “…During the last 15 years, a second and a third generation of lithotripters have been developed. We present the results achieved by primary extracorporeal…”
    Get more information
    Journal Article
  16. 16

    WAF1/p21 regulates proliferation, but does not mediate p53-dependent apoptosis in urothelial carcinoma cell lines by Makri, D, Schulz, W A, Grimm, M, Clasen, S, Bojar, H, Schmitz-Dräger, B J

    Published in International journal of oncology (01-03-1998)
    “…The WAF1/p21 gene product is an inhibitor of cyclin-dependent kinases which can be induced by the tumor suppressor p53 and mediate some of its effects, or…”
    Get more information
    Journal Article
  17. 17

    Differenzialdiagnose der Hämaturie by Horstmann, M., Franiel, T., Grimm, M.O.

    Published in Urologe. Ausgabe A (01-08-2014)
    “…Zusammenfassung Hämaturie ist das Leitsymptom etlicher urologischer und nephrologischer Erkrankungen. Bei der Differenzialdiagnose wird zwischen schmerzhafter…”
    Get full text
    Journal Article
  18. 18

    P53 accumulation in precursor lesions and early stages of bladder cancer by Schmitz-Dräger, B J, van Roeyen, C R, Grimm, M O, Gerharz, C D, Decken, K, Schulz, W A, Bültel, H, Makri, D, Ebert, T, Ackermann, R

    Published in World journal of urology (01-04-1994)
    “…Recent investigations have demonstrated alterations of the p53 tumor-suppressor gene in a considerable number of transitional-cell carcinoma (TCC) specimens…”
    Get full text
    Journal Article
  19. 19

    Perspectives for molecular diagnostics exemplified by urothelial bladder carcinoma by Grimm, M-O, Burchardt, M, Schulz, W A

    Published in Urologe. Ausgabe A (01-05-2003)
    “…The rapidly growing knowledge of molecular mechanisms will change the daily routine of clinicians in the near future. Regarding urothelial bladder carcinoma,…”
    Get full text
    Journal Article
  20. 20

    Interdisciplinary aspects of surgery of the pelvis minor and retroperitoneum by Ackermann, R, Grimm, M O, Bender, H G, Dall, P, Fleisch, M C, Hohenberger, W, Göhl, J, Merkel, S

    Published in Chirurg (01-04-2004)
    “…Surgery of diseases of the pelvis minor and retroperitoneum such as inflammatory disease, malignant tumours, or trauma of pelvic organs need the close…”
    Get full text
    Journal Article